ArticleFrontiers in bioengineering and biotechnology2025

A cross-correction gene therapy approach for CDKL5 deficiency disorder improves the pathological phenotype of CDD patient-derived cortical organoids.

Giorgio Medici et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.